Cyclin D1 overexpression increases stem cell-like behaviors and migrations in estrogen receptor (ER)-positive breast cancer, while the opposite is seen in ER-negative cells, thus reflecting the fundamentally different effects of cyclin D1 expression in ER-positive and ER-negative breast cancers [41]. This evidence concerns the gene ESR1 and breast cancer.